These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 30007470)

  • 1. Mastocytosis: Moving the Field to Precision and Personalized Medicine.
    Castells MC
    Immunol Allergy Clin North Am; 2018 Aug; 38(3):xv-xvii. PubMed ID: 30007470
    [No Abstract]   [Full Text] [Related]  

  • 2. Mast cell disorders: A framework of allergy and hematology symptoms leading to personalized treatments.
    Castells MC
    Ann Allergy Asthma Immunol; 2021 Oct; 127(4):403-404. PubMed ID: 34593102
    [No Abstract]   [Full Text] [Related]  

  • 3. Skin lesions and mast cells.
    Blood; 2008 Jul; 112(1):28. PubMed ID: 18584778
    [No Abstract]   [Full Text] [Related]  

  • 4. A case of 'smouldering' mastocytosis with high mast cell burden, monoclonal myeloid cells, and C-KIT mutation Asp-816-Val.
    Jordan JH; Fritsche-Polanz R; Sperr WR; Mitterbauer G; Födinger M; Schernthaner GH; Christian Bankl H; Gebhart W; Chott A; Lechner K; Valent P
    Leuk Res; 2001 Jul; 25(7):627-34. PubMed ID: 11377687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatic c-KIT activating mutation in urticaria pigmentosa and aggressive mastocytosis: establishment of clonality in a human mast cell neoplasm.
    Longley BJ; Tyrrell L; Lu SZ; Ma YS; Langley K; Ding TG; Duffy T; Jacobs P; Tang LH; Modlin I
    Nat Genet; 1996 Mar; 12(3):312-4. PubMed ID: 8589724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kit Mutations: New Insights and Diagnostic Value.
    Falchi L; Verstovsek S
    Immunol Allergy Clin North Am; 2018 Aug; 38(3):411-428. PubMed ID: 30007460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mastocytosis: advances in diagnosis and treatment.
    Hungness SI; Akin C
    Curr Allergy Asthma Rep; 2007 Jul; 7(4):248-54. PubMed ID: 17547845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolution of urticaria pigmentosa into indolent systemic mastocytosis: abnormal immunophenotype of mast cells without evidence of c-kit mutation ASP-816-VAL.
    Noack F; Escribano L; Sotlar K; Nunez R; Schuetze K; Valent P; Horny HP
    Leuk Lymphoma; 2003 Feb; 44(2):313-9. PubMed ID: 12688351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathology of extramedullary mastocytosis.
    Doyle LA; Hornick JL
    Immunol Allergy Clin North Am; 2014 May; 34(2):323-39. PubMed ID: 24745677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pediatric Expression of Mast Cell Activation Disorders.
    Broesby-Olsen S; Carter M; Kjaer HF; Mortz CG; Møller MB; Kristensen TK; Bindslev-Jensen C; Agertoft L
    Immunol Allergy Clin North Am; 2018 Aug; 38(3):365-377. PubMed ID: 30007457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tyrosine Kinase Inhibition in Mastocytosis: KIT and Beyond KIT.
    Bibi S; Arock M
    Immunol Allergy Clin North Am; 2018 Aug; 38(3):527-543. PubMed ID: 30007468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Systemic mastocytosis and malignant mastocytosis].
    Lortholary O; Casassus P; Laroche L; Lortholary P; Diebold J
    Presse Med; 1990 Jan; 19(3):125-8. PubMed ID: 2137589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New Insights into Clonal Mast Cell Disorders Including Mastocytosis.
    Volertas S; Schuler CF; Akin C
    Immunol Allergy Clin North Am; 2018 Aug; 38(3):341-350. PubMed ID: 30007455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing anaphylactic risk? Consider mast cell clonality.
    Metcalfe DD; Schwartz LB
    J Allergy Clin Immunol; 2009 Mar; 123(3):687-8. PubMed ID: 19281912
    [No Abstract]   [Full Text] [Related]  

  • 15. Genotypic and phenotypic characteristics of Chinese neonates with cutaneous mastocytosis: a case report and literature review.
    Li Y; Li X; Liu X; Kang L; Liu X
    J Int Med Res; 2020 Sep; 48(9):300060520952621. PubMed ID: 32883129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Urticaria pigmentosa: a current approach].
    Pérez-Elizondo AD; Zepeda-Ortega B; del Pino-Rojas GT
    Rev Alerg Mex; 2009; 56(4):124-35. PubMed ID: 19768974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of the Q576R polymorphism in the interleukin-4 receptor alpha chain with indolent mastocytosis limited to the skin.
    Daley T; Metcalfe DD; Akin C
    Blood; 2001 Aug; 98(3):880-2. PubMed ID: 11468192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional deregulation of KIT: link to mast cell proliferative diseases and other neoplasms.
    Cruse G; Metcalfe DD; Olivera A
    Immunol Allergy Clin North Am; 2014 May; 34(2):219-37. PubMed ID: 24745671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Familial urticaria pigmentosa associated with thrombocytosis as the initial symptom of systemic mastocytosis and Down's syndrome.
    Lappe U; Aumann V; Mittler U; Gollnick H
    J Eur Acad Dermatol Venereol; 2003 Nov; 17(6):718-22. PubMed ID: 14761147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Large maculopapular cutaneous lesions are associated with favorable outcome in childhood-onset mastocytosis.
    Wiechers T; Rabenhorst A; Schick T; Preussner LM; Förster A; Valent P; Horny HP; Sotlar K; Hartmann K
    J Allergy Clin Immunol; 2015 Dec; 136(6):1581-1590.e3. PubMed ID: 26152315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.